Japan Tobacco Corporation Reports Strong Financial Growth in Q2 2024

Aug.02.2024
Japan Tobacco Corporation Reports Strong Financial Growth in Q2 2024
Japan Tobacco Inc. (JT) reported a significant financial growth in Q2 2024, with operating income up 14%.

On August 2nd, Japan Tobacco Inc. (JT) released its financial report for the second quarter and first half of 2024, showing significant financial growth for the company in the quarter. In the second quarter, operating income increased by 14% year-on-year to 829.6 billion yen (approximately 55.8 billion USD); net profit also increased by 3.9% year-on-year to 147.9 billion yen (approximately 1 billion USD). For the first six months of the year, operating income increased by 12.7% compared to the same period in 2023, reaching 15,699 billion yen (approximately 106 billion USD); net profit increased by 6.3% year-on-year to 305.2 billion yen (approximately 20.5 billion USD).

Japan Tobacco Corporation Reports Strong Financial Growth in Q2 2024
Financial report for the second quarter and first half of 2024 | Source: JT


Key Financial Highlights for JT in the Second Quarter of 2024 (compared to the second quarter of 2023):


Total revenue increased by 14.0% to reach 829.6 billion yen. Core revenue (calculated at a constant exchange rate) grew by 6.7% to reach 745.7 billion yen. Adjusted operating profit (calculated at a constant exchange rate) increased by 2.0% to reach 223.8 billion yen. Operating profit increased by 4.7% to reach 216.8 billion yen. Net profit increased by 3.9% to reach 147.9 billion yen. Key financial highlights for the first half of 2024 for JT (compared to the first half of 2023) include:


Overall revenue increased by 12.7% to 156.99 billion yen. Core revenue, calculated at constant exchange rates, grew by 6.2% to 142.24 billion yen. Adjusted operating profit, also calculated at constant exchange rates, increased by 2.7% to 45.48 billion yen. Operating profit grew by 4.6% to 43.27 billion yen. Net profit increased by 6.3% to 30.52 billion yen.


Forecast adjustment for the full year 2024:


Income is expected to increase by 930 billion yen, with a full year growth of 9.4%. Core income (calculated at a constant exchange rate) is expected to increase by 200 billion yen, with a full year growth of 4.7%. Adjusted operating profit (calculated at a constant exchange rate) is expected to increase by 170 billion yen, with a full year growth of 2.3%. Operating profit is expected to increase by 120 billion yen, but decrease by 1.8% year-on-year. Net profit is expected to increase by 200 billion yen, but decrease by 1.5% year-on-year. Free cash flow is expected to decrease by 677 billion yen. Masamichi Terabatake, President and CEO of the JT Group, stated:


JT Group performed well in the first half of the year, with strengthened market share and pricing strategies driving growth in the tobacco business. Total sales volume increased by 2.0% year-on-year, with combustible products growing by 1.7% and HNB products (RRP) growing by 25.5%. Particularly in the Japanese market, Ploom sales increased by 36% and expanded in 21 markets globally, with sales steadily rising.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Tobacco-Free Kids Condemns PMI for Marketing Zyn to Youth via F1 Sponsorship
Tobacco-Free Kids Condemns PMI for Marketing Zyn to Youth via F1 Sponsorship
Yolonda C. Richardson, President and CEO of the Campaign for Tobacco-Free Kids, issued a statement on December 10, 2025, condemning Philip Morris International (PMI) for partnering with Ferrari to promote Zyn nicotine pouches on Formula 1 cars. She said PMI’s claim that the sponsorship targets adults is misleading, as F1’s audience has become increasingly young—with over 4 million children aged 8–12 now following the sport.
Dec.12 by 2FIRSTS.ai
PMI’s Smoke-Free Playbook: What Jacek Olczak Really Told Wall Street
PMI’s Smoke-Free Playbook: What Jacek Olczak Really Told Wall Street
At the Morgan Stanley Global Consumer & Retail Conference on December 2, 2025, PMI CEO Jacek Olczak delivered a clear message: the company’s smoke-free shift is now its central strategy. From ZYN’s surge in the U.S. to IQOS’s global momentum and a changing regulatory tone, his remarks sounded less like an earnings update and more like a declaration of PMI’s smoke-free future.
PMI
Dec.03
Special Report | Belarus to centralize vaping market under state supervision
Special Report | Belarus to centralize vaping market under state supervision
Belarus is preparing to overhaul its vaping market under tight state control — from monopolizing imports to banning online sales and restricting retail licenses. Officials say nearly 77% of the disposable e-cigarette market is supplied illegally, prompting sweeping regulatory measures that have already sparked strong pushback from consumers and vape retailers.
Dec.03
MEPs seek Commission answers over EU trade officials’ contacts with PMI
MEPs seek Commission answers over EU trade officials’ contacts with PMI
POLITICO reports that five members of the European Parliament’s health committee want to invite the European Commission to answer questions about its contacts with Philip Morris International (PMI), following a POLITICO and The Examination investigation into extensive meetings between EU trade officials and tobacco lobbyists.
Jan.15 by 2FIRSTS.ai
Malaysia’s MOH aims to implement a vape ban in 2026, starting with open pod systems
Malaysia’s MOH aims to implement a vape ban in 2026, starting with open pod systems
Bernama (Malaysia’s national news agency) reported that Health Minister Datuk Seri Dr Dzulkefly Ahmad said the Ministry of Health aims to implement a vape ban this year, beginning with open pod systems, and will not compromise on enforcing the Control of Smoking Products for Public Health Act 2024 (Act 852).
Jan.06 by 2FIRSTS.ai
ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.
Nov.24 by 2FIRSTS.ai